Used as a chiral building block in the synthesis of pharmaceutical intermediates, particularly in the development of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its structure allows for selective functionalization in peptide-like frameworks, making it valuable in medicinal chemistry for creating fluorinated analogs with improved metabolic stability and bioavailability. Commonly employed in the preparation of protease inhibitors and receptor modulators where the fluorophenyl group influences binding affinity. The Boc-protected amine enables straightforward incorporation into multi-step synthetic sequences, especially in solid-phase and solution-phase peptide synthesis.